Compare Bank of Nova Scotia (BNS) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Nova Scotia vs Eli Lilly And Co — how do they compare? Bank of Nova Scotia trades at $89.03 (market cap $108.32B), while Eli Lilly And Co trades at $1,212.04 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 10× Bank of Nova Scotia's market cap, and Bank of Nova Scotia pays the higher dividend (3.64%). Which is the better fit depends on your goals.
| BNS | LLY | |
|---|---|---|
Market Cap | $108.32B | $1.08T |
Sector | Financials | Health |
52-Week High | $90.29 | $1.24K |
52-Week Low | $56.41 | $639.43 |
Dividend Yield | 3.64% | 0.57% |
Enterprise Value | — | $1.13T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank of Nova Scotia
Bank of Nova Scotia is a global financial services provider. The bank has five business segments: Canadian banking, international banking, global wealth management, global banking and markets, and other. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in Central and South America.
Read more on BNS →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
